Estimating Blood [Lactate] Non-Invasively

Launched by MAYO CLINIC · Sep 2, 2021

Keywords

ClinConnect Summary

This clinical trial is designed to test a new device called LabClasp, which aims to estimate the level of lactate in the blood without needing to draw blood samples. Lactate levels can help doctors understand how well the body is responding to exercise or illness. The study will involve two groups of participants: one group will consist of healthy adults aged 18 and older who do not smoke and can perform high-intensity exercise, while the other group will include adults aged 18 and older who are currently in the Intensive Care Unit (ICU) and have risk factors for a serious infection called sepsis.

If you decide to participate, you will need to give written consent to be part of the study. Participants in the study can expect to wear the LabClasp device, which will monitor lactate levels non-invasively. It’s important to note that individuals with a history of certain cancers, HIV, or who are pregnant cannot participate. This study is not yet recruiting participants, but it aims to gather important information that could help improve how doctors monitor patients' health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria - Aim 1:
• • Subjects must be able to provide written consent.
• • Adults 18 years of age and older.
• • Nonsmokers.
• • No recent hospitalization (\< 60 days).
• • Ability to perform high-intensity exercise.
• Inclusion Criteria - Aim 2:
• • Subjects must be able to provide written consent to be included in the research study.
• • Adults 18 years of age and older.
• • Nonsmokers.
• • Current ICU patient.
• • Have regular blood samples taken for \[lactate\] measurements.
• • Have one or more risk factors for sepsis.
• Exclusion Criteria - Aims 1 and 2:
• • History of, or active malignancy.
• • History of HIV with antiretroviral treatment.
• • Smokers.
• • Pregnancy.